DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 41 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,168,000 | +81.4% | 377,000 | 0.0% | 0.12% | +66.2% |
Q2 2017 | $1,195,000 | -6.8% | 377,000 | 0.0% | 0.07% | -12.9% |
Q1 2017 | $1,282,000 | +18.0% | 377,000 | 0.0% | 0.08% | +19.7% |
Q4 2016 | $1,086,000 | -51.0% | 377,000 | 0.0% | 0.07% | -47.4% |
Q3 2016 | $2,217,000 | +96.0% | 377,000 | 0.0% | 0.14% | +95.7% |
Q2 2016 | $1,131,000 | -44.0% | 377,000 | 0.0% | 0.07% | -38.9% |
Q1 2016 | $2,021,000 | -54.8% | 377,000 | 0.0% | 0.11% | -49.6% |
Q4 2015 | $4,475,000 | +72.8% | 377,000 | +19.6% | 0.22% | +49.3% |
Q3 2015 | $2,589,000 | -32.6% | 315,300 | +14.5% | 0.15% | -27.9% |
Q2 2015 | $3,840,000 | +12.4% | 275,300 | +93.7% | 0.21% | -19.1% |
Q1 2015 | $3,415,000 | +147.6% | 142,100 | +69.8% | 0.26% | +70.2% |
Q4 2014 | $1,379,000 | +70.0% | 83,700 | +31.4% | 0.15% | +33.6% |
Q3 2014 | $811,000 | -43.6% | 63,700 | 0.0% | 0.11% | -42.3% |
Q2 2014 | $1,438,000 | – | 63,700 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |